Galderma
Galderma S.A. is a Swiss pharmaceutical company specializing in dermatological treatments and skin care products. Formerly a subsidiary of L'Oréal and Nestlé, it has been held by a consortium of private institutional investors since 2019.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Aklief | Trifarotene | 2019-10-04 | 2025-2033 | |
| Capex | Fluocinolone | 1990-08-27 | 2027-2030 | |
| Clobex | Clobetasol | 2003-07-24 | 2025-2035 | |
| Desowen | Desonide | 1988-06-15 | 2025-2027 | |
| Differin | Adapalene | 1996-05-31 | 2024-2040 | |
| Epiduo | Adapalene, Benzoyl peroxide | 2008-12-08 | 2024-2040 |
1
2
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use